Alison Maxwell

686 total citations
9 papers, 579 citations indexed

About

Alison Maxwell is a scholar working on Microbiology, Molecular Biology and Immunology. According to data from OpenAlex, Alison Maxwell has authored 9 papers receiving a total of 579 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Microbiology, 4 papers in Molecular Biology and 3 papers in Immunology. Recurrent topics in Alison Maxwell's work include Antimicrobial Peptides and Activities (8 papers), Biochemical and Structural Characterization (4 papers) and Immune Response and Inflammation (2 papers). Alison Maxwell is often cited by papers focused on Antimicrobial Peptides and Activities (8 papers), Biochemical and Structural Characterization (4 papers) and Immune Response and Inflammation (2 papers). Alison Maxwell collaborates with scholars based in United Kingdom, Australia and United States. Alison Maxwell's co-authors include Julia R. Dorin, Jean‐Michel Sallenave, A. John Simpson, Chris Haslett, J. R. W. Govan, John R. W. Govan, Perdita E. Barran, Ross Langley, Dominic J. Campopiano and Nick C. Polfer and has published in prestigious journals such as Journal of Biological Chemistry, FEBS Letters and Infection and Immunity.

In The Last Decade

Alison Maxwell

9 papers receiving 569 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alison Maxwell United Kingdom	9	300	257	190	69	53	9	579
Anne Müller Germany	14	141 0.5×	362 1.4×	278 1.5×	6 0.1×	17 0.3×	20	830
Kanako Sugiyama Japan	13	56 0.2×	286 1.1×	104 0.5×	8 0.1×	96 1.8×	25	565
Gregory R. Moe United States	21	575 1.9×	495 1.9×	141 0.7×	14 0.2×	29 0.5×	39	1.1k
Vicent Esteve Spain	13	46 0.2×	319 1.2×	20 0.1×	24 0.3×	16 0.3×	29	644
Natàlia Jiménez Spain	19	49 0.2×	386 1.5×	190 1.0×	29 0.4×	213 4.0×	47	906
Kazunori Ohki Japan	11	92 0.3×	199 0.8×	104 0.5×	4 0.1×	8 0.2×	24	377
Jens F. Poschet United States	11	26 0.1×	179 0.7×	71 0.4×	15 0.2×	191 3.6×	13	447
Virginie Hervé France	11	48 0.2×	154 0.6×	75 0.4×	5 0.1×	119 2.2×	19	387
R. Presentini Italy	13	47 0.2×	278 1.1×	250 1.3×	25 0.4×	11 0.2×	28	661
Guifeng Sun United States	12	202 0.7×	203 0.8×	82 0.4×	10 0.1×	6 0.1×	20	447

Countries citing papers authored by Alison Maxwell

Since Specialization

Citations

This map shows the geographic impact of Alison Maxwell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison Maxwell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison Maxwell more than expected).

Fields of papers citing papers by Alison Maxwell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison Maxwell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison Maxwell. The network helps show where Alison Maxwell may publish in the future.

Co-authorship network of co-authors of Alison Maxwell

This figure shows the co-authorship network connecting the top 25 collaborators of Alison Maxwell. A scholar is included among the top collaborators of Alison Maxwell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alison Maxwell. Alison Maxwell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

McCullough, Bryan J., Nick C. Polfer, Dominic J. Campopiano, et al.. (2006). Characterisation of DEFB107 by mass spectrometry: Lessons from an anti-antimicrobial defensin. International Journal of Mass Spectrometry. 252(2). 180–188. 11 indexed citations

Semple, Colin A., Alison Maxwell, Philippe Gautier, et al.. (2005). The complexity of selection at the major primate β-defensin locus. BMC Evolutionary Biology. 5(1). 32–32. 39 indexed citations

Maxwell, Alison, Kôichi Hayashi, Karen J. Taylor, et al.. (2005). Antimicrobial Activity of Murine Lung Cells against Staphylococcus aureus Is Increased In Vitro and In Vivo after Elafin Gene Transfer. Infection and Immunity. 73(6). 3609–3617. 33 indexed citations

Campopiano, Dominic J., David J. Clarke, Nick C. Polfer, et al.. (2004). Structure-Activity Relationships in Defensin Dimers. Journal of Biological Chemistry. 279(47). 48671–48679. 80 indexed citations

Barran, Perdita E., Nick C. Polfer, Dominic J. Campopiano, et al.. (2004). Is it biologically relevant to measure the structures of small peptides in the gas-phase?. International Journal of Mass Spectrometry. 240(3). 273–284. 60 indexed citations

Maxwell, Alison, et al.. (2003). Rapid sequence divergence in mammalian β-defensins by adaptive evolution. Molecular Immunology. 40(7). 413–421. 79 indexed citations

Smythe, George A., Anne Poljak, Sonia Bustamante, et al.. (2003). Ecni GC-MS Analysis of Picolinic and Quinolinic Acids and Their Amides in Human Plasma, CSF, and Brain Tissue. Advances in experimental medicine and biology. 527. 705–712. 29 indexed citations

Simpson, A. John, Alison Maxwell, J. R. W. Govan, Chris Haslett, & Jean‐Michel Sallenave. (1999). Elafin (elastase‐specific inhibitor) has anti‐microbial activity against Gram‐positive and Gram‐negative respiratory pathogens. FEBS Letters. 452(3). 309–313. 170 indexed citations

Morrison, Gillian, Donald J. Davidson, Fiona Kilanowski, et al.. (1998). Mouse beta defensin-1 is a functional homolog of human beta defensin-1. Mammalian Genome. 9(6). 453–457. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact